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Patients with primary small cell carcinoma of the liver have
rarely been described in medical literature. Knowledge of
clinical, pathological and immunohistochemical properties
remains limited. We described an 82-year-old female patient
with primary small cell carcinoma of the liver. Histologically,
the tumor showed typical morphology of a pulmonary small
cell carcinoma. Immunohistochemically, the tumor revealed
neuroendocrine differentiation; positive reaction for chromo-
granin, synaptophysin, CD56, and neuron specific enolase.
The tumor was also positive for TTF-1 and c-kit but
completely negative for hepatocyte, carcinoembryonic antigen,
cytokeratin 7; 19; and 20. Herein, we discussed the clinical,
pathological and immunohistochemical findings of extrapul-
monary small cell carcinoma of the liver and reviewed the
relevant literature.
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INTRODUCTION
The most common site of small cell carcinoma
is the lung. It has rarely been found at
extrapulmonary sites such as the trachea, larynx,
thymus, esophagus, stomach, small intestine,
colon, prostate, gallbladder, skin, breast, and
uterine cervix.
1 Small cell carcinoma, involving
primarily the liver, is extremely rare; and only
nine cases have been reported in the literature.
2-7
The clinical and pathological features as well as
immunohistochemical findings have rarely been
reported, furthermore the reported findings are
not always consistent. Here, we report a case of
extrapulmonary small cell carcinoma of the liver
and review of the medical literature.
CASE REPORT
Patient history
An 82-year-old female with hypertension
complained of abdominal discomfort in the right
upper quadrant. She had undergone cholecy-
stectomy and T-tube choledochostomy 2 years
earlier because of gallbladder and common bile
duct stones. Abdominal ultrasonography and
computed tomography revealed a 5.6 cm-sized
liver mass with peripheral rim enhancement (Fig.
1). Lymph node enlargement was present at the
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Fig. 1. Abdominal CT scan shows a 5.6 cm-size liver mass
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aorto-caval area. The patient did not smoke and
was not an alcoholic. Colonoscopy showed a
tubular adenoma at the sigmoid colon. All
laboratory tests, including liver function testing,
peripheral blood counts, and tumor markers such
as carcinoembryonic antigen(CEA), CA19 - 9 and
alpha fetoprotein, were in the normal range.
HBsAg was negative and HBsAb was positive.
Anti-HCV and anti-HIV were negative.
Surgical resection of segment 6 of the liver and
right hemicolectomy due to hepatic adhesion was
performed. The tumor and non-tumor liver tissue
were formalin-fixed and paraffin embedded. After
surgery, bronchial washing, chest computed
tomography (CT) and PET-CT were performed to
exclude primary pulmonary small cell carcinoma;
and there was no evidence of lung cancer. Post
operative chemotherapy was not performed
because the patient refused further treatment due
to her advanced age. Seven months after surgery,
1.1 cm to 2.8 cm-sized multiple hepatic nodules
developed with enlargement of the lymph nodes
at the porta hepatic, aortocaval, and portocaval
areas. No pulmonary abnormalities were detected.
Oral etoposide treatment was started because the
patient’s general condition was poor and she had
been receiving anticoagulant therapy due to atrial
fibrillation. Two months after chemotherapy, the
size of the hepatic nodules and lymph nodes
decreased. The patient is currently alive 1.5 years
post-surgery without significant problems.
Immunohistochemistry
Paraffin blocks were used for hematoxylin-eosin
staining and immunohistochemistry. The primary
antibodies are listed in Table 1.
Pathologic finding and results of immunohistoche-
mical staining
Grossly, the tumor was 6.7 × 5.5 × 5.5 cm with a
nodular expanding tumor border (Fig. 2) that
involved Glisson’s capsule and invaded the
pericolic fat. The cut surface of the tumor was
yellow, tan, and friable with necrotic areas. Portal
Table 1. Primary Antibodies and Pretreatment Protocols
Antibody Clone Source Dilution Pretreatment
Chromogranin DAK-A3 DAKO 1 : 100 Microwave
Synaptophysin SY38 DAKO Predilution Microwave
CD56 1B6 Novocastra 1 : 100 Autoclave
CD57 NK1 Neomarker 1 : 100 Autoclave
NSE BBS/NC/VI-H14 DAKO 1 : 60 Microwave
TTF-1 8G7G3/1 Neomarker 1 : 100 Autoclave
Hepatocyte OCHIE5 DAKO 1 : 200 Autoclave
Alpha-fetoprotein Polyclonal DAKO 1 : 400 No
CEA II-7 DAKO 1 : 100 Microwave
CK7 V-TL12/30 DAKO 1 : 100 Microwave
CK19 BA17 DAKO 1 : 150 Microwave
CK20 Q2 Neomarker 1 : 150 Autoclave
C-kit Polyclonal DAKO 1 : 500 Autoclave
Vimentin Vim3B4 DAKO 1 : 300 Microwave
Desmin D33 DAKO 1 : 150 Microwave
S-100 protein Polyclonal DAKO 1 : 3200 NoSuk Jin Choi, et al.
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vein invasion was absent. The background liver
was not cirrhotic.
Histologically, the tumor was composed of
small round cells with multifocal necrosis,
morphologically similar to pulmonary small cell
carcinoma (Fig. 3A). An insular and trabecular
pattern was not observed. The tumor cells showed
hyperchromatic nuclei with a "salt and pepper"
pattern of finely dispersed chromatin, indistinct
nucleoli, and frequent mitoses (Fig. 3B). Nuclear
moldings and crush artifacts were present. The
tumor cells were diffusely positive for synaptophysin,
chromogranin, CD56, neuron specific enolase
(NSE), thyroid transcription factor-1 (TTF-1) and
c-kit (Fig. 4A, B). On the other hand, cytokeratin
7; 19; and 20; CEA; alpha fetoprotein; hepatocyte;
vimentin; desmin; and S-100 protein were all
negative. There was no hepatocellular carcinoma
or adenocarcinoma component. Multiple enlarged
lymph nodes were identified two of which
showed metastatic small cell carcinoma.
Fig. 2. Grossly, the well demarcated tumor shows central
necrosis and cystic change.
Fig. 3. Microscopic findings of the tumor reveal solid
small round cells and necrosis (A). The tumor cells show
oval to fusiform hyperchromatic nuclei and indistinct
nucleoli with frequent mitoses (B).
Fig. 4. Immunohistochemical staining for CD56 (A) and
synaptophysin (B) reveals a strong positive reaction.
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DISCUSSION
Extrapulmonary small cell carcinoma has been
reported to occur in 0.1 - 0.4% of all malignancies.
8
Extrapulmonary small cell carcinoma shows
neuroendocrine differentiation, but it is not
synonymous with neuroendocrine carcinoma.
Primary neuroendocrine carcinomas of the liver
may show solid, trabecular and insular arrangements
reminiscent of a carcinoid;
9-12 however, extrapul-
monary small cell carcinoma of the liver is
histologically indistinguishable from metastatic
pulmonary small cell carcinoma to the liver.
Therefore, exclusion of pulmonary small cell
carcinoma is a prerequisite for the diagnosis of
extrapulmonary small cell carcinoma. In our case,
the tumor showed homogeneous small cell
features without a carcinoid-like pattern. There
was no pulmonary lesion detected on a chest
X-ray, chest CT, PET-CT, or bronchoscopy.
Approximately half of the small cell carcinomas
that develop in the gastrointestinal tract contain
non-small cell carcinoma elements;
13 but our case
had pure small-cell morphology without features
of hepatocellular carcinoma or biliary adenocar-
cinoma.
The results of immunohistochemical staining of
small cell carcinoma occurring in the liver vary.
Table 2. Clinicopathological and Immunohistochemical Features of Extrapulmonary Small Cell Carcinoma of the Liver
Author Age Sex Symptom Size Viral marker
Serum AFP
(ng/mL)
Cirrhosis
Immunohistochemical
staining
Treatment
Status/survival
(months)
Ryu et al.
2 56 M RUQ pain,
general
weakness
8 cm HBsAg (-)
HBsAb (+)
Anti-HCV (-)
3.24 Absent (+) CD56, c-kit, SYN
(-) TTF-1
CT (cisplatin,
etoposide,
irinotecan)
AWD
Kim et al.
3 53 M Palpable
mass
12 cm HBsAg (-)
HBsAb (-)
2.94 Absent (+) CD56, NSE, c-kit, SYN,
mixed CK, EMA
(-) CK7, 8, 19, 20, AFP,
CEA, hepatocyte, vimentin,
desmin, TTF-1
Segmentectomy
& adjuvant CT
(cisplatin,
etoposide)
AWD
Zanconati
et al.
5
56 M Abdominal
discomfort
5 cm >200 Absent (+) AE1/AE3, CK8, 18, 19,
NSE, AFP, ERY-1
(-) S-100 protein, CEA
Partial hepatectomy MI
Zanconati
et al.
5
69 M DM,
weight loss
10 cm HBcAg (+) Absent (+) AE1/AE3, CK 8, 18, 19,
(+/-) NSE, CHR
(-) S-100 protein, CEA
No DOD/1
Zanconati
et al.
5
89 M Jaundice 6 cm 150 Absent (+) AE1/AE3, CK 8, 18, 19,
AFP, NSE,
(-) CHR, S-100 protein,
CEA
No DOD/1
Kim et al.
6 67 M Abdominal
discomfort
12 cm HBsAg (-)
HBsAb (+)
Anti-HCV (-)
Normal Absent (+) SYN, CD56, c-kit
(-) CK, CEA, AFP
CT (cisplatin,
epirubicin)
AWD
Sengoz et
al.
4
73 F Right
hemihepatectomy
DOD/67
Sengoz et
al.
4
66 M CT (Cisplatin) DOD/13
Kim et al.
7 (+) CHR, SYN
This case 82 F Abdominal
discomfort
6.7 cm HBsAg (-)
HBsAb (+)
Anti-HCV (-)
3.4 Absent (+) CD56, NSE,
SYN, CHR,TTF-1, c-kit
(-) Antihepatocyte, AFP,
vimentin, desmin, CK7, 19,
20, CEA, S-100 protein
Segmentectomy
CT (etoposide)
AWD
RUQ, right upper quadrant; DM, diabetes mellitus; SYN, synaptophysin; CHR, chromogranin; CT, chemotherapy; MI, myocardial infarction; AWD, alive
with disease; DOD, dead of disease.Suk Jin Choi, et al.
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Recently reported cases, including this case, were
positive for more than 2 neuroendocrine markers
such as CD56, synaptophysin, or chromogranin.
2,3,8
Although TTF-1 is usually positive in pulmonary
small cell carcinomas (about 96%),
14 its expression
is not constant in extrapulmonary small cell
carcinoma. Two cases of small cell carcinoma of
the liver previously reported were negative for
TTF-1,
2,3 but our case was positive. TTF-1 expres-
sion has been reported in some extrapulmonary
small cell carcinomas occurring in the gastroin-
testinal tract, urinary bladder, uterine cervix,
prostate, thyroid gland, and breast and it is not
a specific marker for pulmonary small cell
carcinoma.
14-17 Cytokeratin expressions have been
studied in small cell carcinomas of the liver.
3,5
Kim et al.
3 reported that a tumor was negative for
CK7, 19 and 20, in agreement with our case.
However, Zanconati et al.
5 reported that
AE1/AE3, cytokeratin 8, 18, and 19 were positive
for tumors in all of the 3 cases that they reported.
These cytokeratins are expressed more commonly
in cholangiocarcinoma than in hepatocellular
carcinoma and have negative reactions with
neuroendocrine markers except for NSE, which is
less specific than chromogranin. The immunopheno-
type of the 3 cases reported by Zanconati et al.
5
were more compatible with a carcinoma showing
biliary differentiation rather than neuroendocrine
differentiation. The study of more cases is needed
to characterize in detail the immunophenotype of
primary hepatic small cell carcinoma.
Regarding the origin of neuroendocrine cells,
differentiation and proliferation from biliary
epithelium have been favored because bile ducts
contain neuroendocrine argentaffin cells. However,
neuroendocrine differentiation from stem cell
theory should also be considered because the
tumor cells were found to express c-kit, a stem
cell marker of the liver, in 4 recently reported
cases including ours.
The clinical and pathological findings of
primary small cell carcinoma of the liver are
summarized in Table 2. The clinical features such
as low alpha fetoprotein and absence of viremia
or cirrhosis are different from conventional
hepatocellular carcinoma. Extrapulmonary small
cell carcinomas generally show rapid progression
with distant metastases and poor prognosis. Small
cell carcinoma of the liver is rare and the infor-
mation on the clinical course is limited. Sengoz et
al.
4 reported 2 cases of extrapulmonary small cell
carcinoma of the liver, 1 of which survived for 13
months after chemotherapy and the other for 67
months after right hemihepatectomy. Zanconati et
al.
5 reported 2 cases that were acutely fatal. In our
case, the patient did not receive the standard
chemotherapy of small cell carcinoma because of
her advanced age, poor general condition, and
atrial fibrillation. Fortunately, she showed
response to oral etoposide that was given after
recurrence. She is still alive after 1.5 years later
without significant clinical complications. In
general, the treatment of extrapulmonary small
cell carcinoma is organ resection and adjuvant
chemotherapy using the same regimen as with
pulmonary small cell carcinomas.
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